Leader
Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Patients undergoing major hip or knee surgery are particularly
prone to postoperative venous thromboembolism (VTE)
that is, deep
venous thrombosis (DVT) and pulmonary embolism (PE). Without thromboprophylaxis, the incidence of DVT in such patients is more than
50%, and fatal PE occurs in 1-6%.1 These data are based on studies in which, predominantly, patients with osteoarthritis (OA)
were investigated.
It is not known whether or not there is a significant difference in the risk for developing VTE between patients with rheumatoid arthritis (RA) and those with OA undergoing major orthopaedic surgery as adequate investigations are lacking.2
| |
Thromboprophylaxis during hospitalisation |
|---|
During the past three decades, numerous investigations documented the efficacy of unfractionated heparin, pneumatic compression, warfarin, and low molecular weight heparin (LMWH) in reducing the incidence of postoperative VTE.
Nowadays, LMWH is the most commonly applied thromboprophylactic agent
in most orthopaedic surgery units in Europe. The evidence for the
efficacy and safety of LMWH
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
